Browsing Tag
Bausch + Lomb
5 posts
Bausch + Lomb closes €675m secured notes offering and expands credit agreement with new $2.325bn term loan facility
Bausch + Lomb finalizes €675M notes offering and $2.325B loan refinancing to optimize debt structure and support future eye health innovation.
Will Bausch + Lomb break free from debt-heavy Bausch Health? Sale rumours ignite market frenzy!
Bausch + Lomb saw its stock surge by 13% in Toronto, trading at 24.01 Canadian dollars (around $17.67),…
Bausch + Lomb completes XIIDRA acquisition to fortify dry eye offering
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a prominent global eye health company, has successfully wrapped up its acquisition…
Bausch + Lomb acquires Johnson & Johnson Vision’s Blink product line
Bausch + Lomb, an esteemed global eye health company, has broadened its portfolio by purchasing Johnson & Johnson…
Bausch + Lomb to acquire dry eye disease medication XIIDRA from Novartis
Bausch + Lomb has reached a definitive agreement with Novartis to acquire the non-steroid eye drop XIIDRA (lifitegrast…